Company Overview
Established in 1916, CSL is a global biotechnology leader driven by our promise to save lives. CSL – including our two businesses CSL Behring and Seqirus – employs more than 22,000 people and provides a dynamic portfolio of life-saving medicines to more than 60 countries, including therapies that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Our unique commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. For inspiring stories about the promise of biotechnology, visit Vita at and follow us on